Vincent Lawton
Vorsitzender bei ADDEX THERAPEUTICS LTD
Vermögen: 199 059 $ am 31.05.2024
Aktive Positionen von Vincent Lawton
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADDEX THERAPEUTICS LTD | Independent Dir/Board Member | - | - |
Vorsitzender | - | - | |
Direktor/Vorstandsmitglied | 13.05.2010 | 27.06.2014 | |
Corporate Officer/Principal | 19.04.2009 | 13.05.2010 | |
AQIX Ltd.
AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay. | Vorsitzender | - | - |
Karriereverlauf von Vincent Lawton
Ehemalige bekannte Positionen von Vincent Lawton
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medicines & Healthcare Products Regulatory Agency | Direktor/Vorstandsmitglied | 01.01.2008 | 01.01.2015 |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Vorstandsvorsitzender | - | 01.01.2006 |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Präsident | 01.01.2004 | 01.01.2006 |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Ministerial Industry Strategy Group | Corporate Officer/Principal | - | - |
Pharmaceutical Industry Competitiveness Task Force | Gründer | - | - |
Corporate Officer/Principal | - | - | |
United Kingdom Department of Health & Social Care | Gründer | - | - |
Corporate Officer/Principal | - | - | |
░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Vincent Lawton
University of London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 10 |
Schweiz | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 6 |
Founder | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 5 |
Government | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ADDEX THERAPEUTICS LTD | Health Technology |
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Commercial Services |
UK Clinical Research Collaboration | |
United Kingdom Department of Health & Social Care | Government |
Pharmaceutical Industry Competitiveness Task Force | Government |
Medicines & Healthcare Products Regulatory Agency | Government |
AQIX Ltd.
AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay. | Health Technology |
Ministerial Industry Strategy Group |
- Börse
- Insiders
- Vincent Lawton
- Erfahrung